|Bid||0.00 x 900|
|Ask||159.00 x 800|
|Day's range||103.94 - 107.42|
|52-week range||60.20 - 137.95|
|Beta (3Y Monthly)||0.39|
|PE ratio (TTM)||31.60|
|Earnings date||23 Oct 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||136.33|
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...
Here's what has made the best healthcare stocks of this young century the best -- and why some stocks could be poised to join the club.
Does Herbalife Stock Have Room for More Growth? Herbalife’s US sales were disrupted due to the business transition following the Federal Trade Commission agreement. Herbalife raised the fiscal 2018 guidance for worldwide volume point growth, which indicates that the growth momentum will likely be sustained in the coming quarters.
Herbalife stock has risen 61.5% on a YTD (year-to-date) basis as of September 25. Usana Health Sciences (USNA) stock has risen 63.7% YTD, while Vitamin Shoppe (VSI) stock has nearly tripled. Herbalife stock has benefited from the company’s strong financial performance in the first half of fiscal 2018.
Assessing USANA Health Sciences Inc’s (NYSE:USNA) past track record of performance is a valuable exercise for investors. It enables us to reflect on whether the company has met or exceedRead More...
Will Herbalife’s Strong Q2 2018 Results Lift Its Stock? Herbalife’s top line also improved substantially in the United States, which instilled confidence in its stock. Herbalife’s management raised its full year guidance for worldwide volume point growth, which indicates that the company is likely to sustain its growth momentum in the second half of 2018.
Shares of Herbalife (HLF) rose 2.6% in after-hours trading following the company’s stronger-than-expected second-quarter results on August 1. Herbalife’s second-quarter sales marked double-digit growth and exceeded analysts’ expectations thanks to growth across most of its regions. Buoyed by a stellar performance in the first half of 2018, the company raised its guidance for worldwide volume points.
The Salt Lake City-based company said it had profit of $1.36 per share. The nutritional supplement maker posted revenue of $301.5 million in the period. USANA Health expects full-year earnings to be $4.75 ...
ConocoPhillips, Churchill Downs, Wingstop, Usana Health and Marathon Oil are top stocks closing in on buy points from bullish flat bases.
USANA Health Sciences Inc (NYSE:USNA), a personal products company based in United States, saw a significant share price rise of over 20% in the past couple of months on theRead More...
Does the share price for USANA Health Sciences Inc (NYSE:USNA) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value using the discounted cash flow (DCF) method. IfRead More...
Herbalife Nutrition (HLF) sustained its growth momentum in 1Q18 and reported strong results. The company’s top line benefited from strong EMEA (Europe, the Middle East, and Africa) and Asia-Pacific market growth, primarily in India and Indonesia. The company returned to growth in its US business, which is a big positive. Going forward, Herbalife’s top line is expected to grow healthily in future quarters, reflecting improved Asia-Pacific and EMEA performance and favorable currency rates. Also, US volumes are expected to improve.
Herbalife Nutrition (HLF) stock has followed a strong uptrend due to improving fundamentals. Herbalife rose ~41% in 2017, and 2018 has turned out to be another great year for the stock, which had risen ~64% YTD (year-to-date) as of May 4. Herbalife reported its 1Q18 results on May 3. Given the strong stock run so far this year, activist investor Bill Ackman, who once called Herbalife a pyramid scheme and betted against the stock, exited his short position against Herbalife.
The Salt Lake City-based company said it had net income of $1.19 per share. The nutritional supplement maker posted revenue of $292 million in the period. USANA Health expects full-year earnings to be ...
Of the analysts covering Herbalife (HLF) stock, 50% of them are recommending a “buy,” and 50% are recommending a “hold.” Herbalife’s sales and profitability were subdued in the first three quarters of 2017. Herbalife’s financials are expected to remain challenged in the near term, given the weakness in its key regions. Currently, analysts have a price target of $86.80 per share for Herbalife stock, which represents an upside of 3.5% compared to its closing price of $83.88 on February 15, 2018.
The Salt Lake City-based company said it had a loss of 24 cents per share. Earnings, adjusted for pretax expenses and non-recurring costs, were $1.11 per share. The nutritional supplement maker posted ...